FINWIRES · TerminalLIVE
FINWIRES

Arm's Fiscal Q1 Slight Beat Supported by Data Center Strength, RBC Says

By

Arm's (ARM) fiscal Q1 results were slightly better than consensus expectations as data center royalties more than doubled and helped offset lackluster Android trends, RBC Capital Markets said in a note Thursday.

Arm's Licensing business is "tracking ahead" and the company now has "higher confidence" in upside to its over $1 billion AGI CPU estimates, RBC said. However, 2027 royalty guidance was lowered amid Android weakness, the note said.

RBC said its estimates for Arm moved up slightly due to strength in the Licensing segment, and also as the investment firm sees "further upside potential as additional wafer supply becomes available."

The investment firm raised the company's 2027 earnings per share estimate to $2.30 from $2.18, and the 2028 EPS estimate to $3.17 from $3.12.

RBC said it still sees Arm as an "outsized beneficiary from Agentic AI-driven CPU growth" and believes that a "recent pull back makes risk/reward attractive."

The investment firm kept its outperform rating on Arm, and lowered the company's price target to $340 from $475, citing peer multiple contraction.

Arm shares were up past 4% in late morning trading.

Price: $234.83, Change: $+9.94, Percent Change: +4.42%

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT